Fragile-X Carrier Screening and the Prevalence of Premutation and Full-Mutation Carriers in Israel

Bonthron, 1993, Population screening for fragile-X syndrome, Lancet, 341, 769, 10.1016/0140-6736(93)90552-R Brown, 1993, Rapid fragile X carrier screening and prenatal diagnosis using a nonradioactive PCR test, JAMA, 270, 1569, 10.1001/jama.1993.03510130075034 Bundey, 1993, Population screening for fragile-X syndrome, Lancet, 341, 770 Central Bureau of Statistics, 1999 Dar, 1995, Ethnic distribution of the fragile X syndrome in Israel: evidence of founder chromosomes(?), Isr J Med Sci, 31, 323 de Vries, 1996, Mental status of females with an FMR1 gene full mutation, Am J Hum Genet, 58, 1025 Drasinover, 2000, Increased transmission of intermediate alleles of the FMR1 gene compared with normal alleles among female heterozygotes, Am J Med Genet, 93, 155, 10.1002/1096-8628(20000717)93:2<155::AID-AJMG13>3.0.CO;2-G Falik-Zaccai, 1997, Predisposition to the fragile X syndrome in Jews of Tunisian descent is due to the absence of AGG interruptions on a rare Mediterranean haplotype, Am J Hum Genet, 60, 103 Finucane, 1996, Should all pregnant women be offered carrier testing for fragile X syndrome?, Clin Obstet Gynecol, 39, 772, 10.1097/00003081-199612000-00006 Fu, 1991, Variation of the CGG repeat at the Fragile X site results in genetic instability: resolution of the Sherman paradox, Cell, 67, 1047, 10.1016/0092-8674(91)90283-5 Ginsberg, 1994, Cost-benefit analysis of a national screening program for cystic fibrosis in an Israeli population, Health Econ, 3, 5, 10.1002/hec.4730030104 Ginsberg, 1998, Cost-benefit analysis of a national thalassemia prevention program in Israel, J Med Screen, 5, 120, 10.1136/jms.5.3.120 Herman, 1997, First trimester ultrasound screening for nuchal translucence as marker of Down’s syndrome, Harefuah, 132, 94 Howard-Peebles, 1993, Population screening for fragile-X syndrome, Lancet, 341, 770 Kremer, 1991, Mapping of DNA instability at the fragile X to a trinucleotide repeat sequence p(CCG)n, Science, 252, 1711, 10.1126/science.1675488 Murray, 1997, Screening for fragile X syndrome: information needs for health planners, J Med Screen, 4, 60, 10.1177/096914139700400204 Murray, 1996, Population screening at the FRAXA and FRAXE loci: molecular analyses of boys with learning difficulties and their mothers, Hum Mol Genet, 5, 727, 10.1093/hmg/5.6.727 Nolin, 1996, Familial transmission of the FMR1 CGG repeat, Am J Hum Genet, 59, 1252 Nolin, 1991, Fragile X screening program in New York State, Am J Med Genet, 38, 251, 10.1002/ajmg.1320380218 Oberlé, 1991, Instability of a 550-base pair DNA segment and abnormal methylation in fragile X syndrome, Science, 252, 1097, 10.1126/science.252.5009.1097 Palomaki, 1993, Is it time for population-based prenatal screening for fragile-X?, Lancet, 341, 373, 10.1016/0140-6736(93)90176-H Park, 1994, Fragile X syndrome: diagnostic and carrier testing, Am J Med Genet, 53, 380, 10.1002/ajmg.1320530416 Pesso, 1997, No founder effect detected in Jewish Ashkenazi patients with fragile-X syndrome, Hum Genet, 101, 186, 10.1007/s004390050611 Pesso, 2000, Screening for fragile X syndrome in women of reproductive age, Prenat Diagn, 20, 611, 10.1002/1097-0223(200008)20:8<611::AID-PD881>3.0.CO;2-M Pieretti, 1991, Absence of expression of the FMR-1 gene in fragile X syndrome, Cell, 66, 817, 10.1016/0092-8674(91)90125-I Rousseau, 1991, Direct diagnosis by DNA analysis of the fragile X syndrome of mental retardation, N Engl J Med, 325, 1673, 10.1056/NEJM199112123252401 Rousseau, 1994, High throughput and economical mutation detection and RFLP analysis using a mini-method for DNA preparation from whole blood and acrylamide gel electrophoresis, Hum Mutat, 4, 51, 10.1002/humu.1380040107 Rousseau, 1995, Prevalence of carriers of premutation-size alleles of the FMRI gene-and implications for the population genetics of the fragile X syndrome, Am J Hum Genet, 57, 1006 Ryynänen, 1999, Feasibility and acceptance of screening for fragile X mutations in low-risk pregnancies, Eur J Hum Genet, 7, 212, 10.1038/sj.ejhg.5200285 Schwartz, 1988, Fragile X syndrome: incidence, clinical and cytogenetic findings in the black and white populations of South Carolina, Am J Med Genet, 30, 641, 10.1002/ajmg.1320300165 Sherman, 1994, Characteristics of the transmission of the FMR1 gene from carrier females in a prospective sample of conceptuses, Am J Med Genet, 51, 503, 10.1002/ajmg.1320510442 Spence, 1996, Molecular fragile X screening in normal populations, Am J Med Genet, 64, 181, 10.1002/(SICI)1096-8628(19960712)64:1<181::AID-AJMG31>3.0.CO;2-H Turner, 1986, Preventive screening for the fragile X syndrome, N Engl J Med, 315, 607, 10.1056/NEJM198609043151002 Turner, 1996, Prevalence of fragile X syndrome, Am J Med Genet, 64, 196, 10.1002/(SICI)1096-8628(19960712)64:1<196::AID-AJMG35>3.0.CO;2-G Tzeng, 1999, Pilot fragile X screening in normal population of Taiwan, Diagn Mol Pathol, 8, 152, 10.1097/00019606-199909000-00008 Verkerk, 1991, Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome, Cell, 65, 905, 10.1016/0092-8674(91)90397-H Warren, 1994, Advances in molecular analysis of fragile X syndrome, JAMA, 271, 536, 10.1001/jama.1994.03510310066040 Wildhagen, 1999, Efficacy of cascade testing for fragile X syndrome, J Med Screen, 6, 70, 10.1136/jms.6.2.70 Wildhagen, 1998, Explorative study of costs, effects and savings of screening for female fragile X premutation and full mutation carriers in the general population, Community Genet, 1, 36, 10.1159/000016133 Yu, 1991, Fragile X genotype characterized by an unstable region of DNA, Science, 252, 1179, 10.1126/science.252.5009.1179